Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Immunicon
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Measurable metastatic carcinoma of the colon or rectum.
1st or 2nd line chemotherapy (3rd line acceptable with epidermal growth factor receptor \[EGFR\] targeted therapy)
Chest/abdomen/pelvis scans every 6-12 weeks
ECOG 0-2
Hemoglobin (Hgb) \> or = 8g/dl within 7 days prior to enrollment
Age \> or = to 18 years of age
You may not be if
Cumulative weekly blood draws exceeding 150mL/week
Brain metastasis
Prior history of other carcinoma within the last 5 years, except ductal carcinoma in situ (DCIS), non-invasive cervical cancer or non-melanoma skin cancer
Surgery within 14 days of the initial blood draw, excluding surgical placement of a central venous device
